Key takeaways
- Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced that the Centers for Medicare & Medicaid Services (CMS) would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately,” though he did not identify the specific statutory basis for the delegation, during a July 21, 2026 press conference on combatting healthcare fraud broadcast by C-SPAN.
- Providers may now face exclusion action initiated through either CMS or the Office of Inspector General (OIG), although the division of responsibility between the agencies remains unclear.
- No formal delegation order, Federal Register notice or procedural guidance has been published, leaving critical operational questions unanswered.
- Providers accustomed to the pace and procedural rhythm of OIG enforcement should not assume CMS, which has real-time access to claims data and enrollment information, will follow the same playbook.
Putting the delegation into effect
Section 1128 assigns exclusion authority to the Secretary of HHS. Although Congress expressly authorized the Secretary to delegate certain investigative functions to OIG in 2010, it did not separately address delegation of the exclusion function. At the same time, Congress did not expressly prohibit delegation of that authority and HHS has historically exercised broad authority to delegate many functions of the Secretary within HHS. Secretary Kennedy nevertheless announced that CMS would receive that authority "effective immediately." Both CMS Administrator Dr. Mehmet Oz and Inspector General Christi March Bell publicly endorsed the expansion, with the Inspector General characterizing it as "a force multiplier" for HHS's existing enforcement capacity.
The delegation is reportedly in effect, but the absence of a publicly available delegation instrument or implementing guidance leaves important questions unresolved. Regulations found at 42 C.F.R. § 1005.4 generally prevent an Administrative Law Judge from invalidating a secretarial delegation in an exclusion appeal. Unresolved is whether CMS may use OIG’s existing procedures unchanged, whether additional agency action is required to implement the delegation operationally, or whether affected parties could raise procedural challenges in another forum. The more immediate questions are therefore procedural: which exclusion grounds CMS will invoke, what notice and hearing process will apply and how CMS and OIG will divide responsibility.
Converging administrative functions
OIG and CMS approach enforcement from different institutional positions. OIG typically excludes providers after an investigation, a process that may take years. CMS, by contrast, processes claims, manages enrollment and conducts program-integrity reviews in real time. With exclusion authority, CMS could move from a UPIC audit, enrollment review or possibly artificial intelligence (AI)-enabled data analyses to an exclusion proceeding without an intervening OIG investigation provided the statutory basis for exclusion is otherwise satisfied.
At the C-SPAN press conference, OIG described the change as expanding HHS’s enforcement capacity and noted that it imposed approximately 2,600 exclusions in the prior fiscal year. Because CMS contractors already review thousands of providers annually, using even some of those reviews to initiate exclusions could significantly increase both the speed and volume of enforcement.
What remains unresolved
HHS has not said whether CMS will use OIG’s Part 1001 framework, whether CMS will develop supplemental procedures or guidance, how mandatory and discretionary exclusion authorities will be administered or how CMS and OIG will coordinate overlapping matters. Nor has HHS explained how CMS will issue notices, identify effective dates, publish exclusions, handle appeals and reinstatement or communicate procedural guidance. The applicable statutory protections must still be honored, but the forum, timing and mechanics remain unclear.
That uncertainty should not be mistaken for delay. CMS already has the claims, enrollment and audit data needed to identify potential targets and may view the delegation as immediately operative. Providers should therefore assess whether routine CMS interactions could surface conduct that may support a statutory basis for exclusion, revisit escalation, investigation, refund and self-disclosure protocols. Providers should also consider whether exclusion may become a risk to arise earlier in the lifecycle of an audit, enrollment review or program integrity inquiry than has historically been the case under the traditional OIG-led model.
A broader enforcement trend
The delegation does not exist in isolation. Across multiple rulemakings this year, CMS has been building the infrastructure to identify, flag and act against providers faster and more independently than its existing tools previously allowed. Notably, many of CMS’s existing program-integrity tools, including payment suspensions, enrollment denials, enrollment revocations and reenrollment bars, already operate independently of exclusion authority. The delegation therefore should be viewed as an expansion of CMS’s enforcement arsenal rather than a replacement for existing remedies.
A proposed rule under the CRUSH initiative (Comprehensive Regulations to Uncover Suspicious Healthcare) is under White House review and would strengthen CMS's authority over provider enrollment, medical review and program-integrity oversight across Medicare, Medicaid and CHIP. The FY 2027 hospice final rule established a Service and Spending Variation Index that uses claims data to identify hospices for program integrity review. The proposed CY 2027 home health rule would broaden enrollment-denial and revocation grounds and permit reapplication bars of up to 10 years. CMS has also imposed temporary nationwide enrollment moratoria for home health agencies, hospices and certain DME suppliers. Exclusion authority adds the most consequential enforcement remedy to that growing set of tools.
Conclusion
CMS now reportedly possesses delegated exclusion authority to complement the data and administrative tools it has long possessed. The critical question is how CMS will use that authority and whether exclusion becomes a more immediate consequence of audits, enrollment reviews and other routine oversight. For compliant providers, the concern is not just the risk of exclusion itself but the administrative and legal costs of operating in an enforcement environment designed for the worst cases.